Isoflavones and cognitive function in older women:: the SOy and Postmenopausal Health In Aging (SOPHIA) Study

被引:127
|
作者
Kritz-Silverstein, D [1 ]
Von Mühlen, D [1 ]
Barrett-Connor, E [1 ]
Bressel, MAB [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA
关键词
cognitive function; isoflavones; menopause; postmenopausal women; verbal memory;
D O I
10.1097/00042192-200310030-00004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study examines the effects of a dietary supplement of isoflavones on cognitive function in postmenopausal women. Design: Participants for this 6-month, double-blind, randomized, placebo-controlled clinical trial were women who were in good health, were postmenopausal at least 2 years, and were not using estrogen replacement therapy. Between July 24,2000, and October 31,2000, 56 women aged 55 to 74 years were randomized; 2 in the placebo group and I in the active treatment group did not complete the 6-month evaluation, and none withdrew because of adverse effects. Women randomized to active treatment (n = 27) took two pills per day, each containing 55 mg of soy-extracted isoflavones (I 10 mg total isoflavones per day; Healthy Woman: Soy Menopause Supplement, Personal Products Company, McNeil-PPC Inc., Skillman, NJ, USA). Women assigned to placebo (n = 26) took two identical-appearing pills per day containing inert ingredients. Cognitive function tests administered at baseline and follow-up included the following: Trails A and B, category fluency, and logical memory and recall (a paragraph recall test assessing immediate and delayed verbal memory). Results: At baseline, all women were cognitively intact; there were no significant differences by treatment assignment in age, education, depressed mood, or cognitive function (all P values > 0.10). Compliance was 98% and 97%, respectively, in the placebo and treatment groups; all women took at least 85% of their pills. The women in the treatment group did consistently better, both as compared with their own baseline scores and as compared with the placebo group responses at 6 months. Comparisons of percentage change in cognitive function between baseline and follow-up showed greater improvement in category fluency for women on active treatment as compared with the case of those on placebo (P = 0.02) and showed (nonsignificantly) greater improvement on the two other tests of verbal memory and Trails B. Conclusion: These results suggest that isoflavone supplementation has a favorable effect on cognitive function, particularly verbal memory, in postmenopausal women.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 50 条
  • [41] Cognitive Function and Fine Motor Speed in Older Women with Diabetes Mellitus: Results from the Women's Health Initiative Study of Cognitive Aging
    Espeland, Mark A.
    Miller, Michael E.
    Goveas, Joseph S.
    Hogan, Patricia E.
    Coker, Laura H.
    Williamson, Jeff
    Naughton, Michelle
    Resnick, Susan M.
    JOURNAL OF WOMENS HEALTH, 2011, 20 (10) : 1435 - 1443
  • [42] Subtypes of Mild Cognitive Impairment in Older Postmenopausal Women The Women's Health Initiative Memory Study
    Rapp, Stephen R.
    Legault, Claudine
    Henderson, Victor W.
    Brunner, Robert L.
    Masaki, Kamal
    Jones, Beverly
    Absher, John
    Thal, Leon
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2010, 24 (03): : 248 - 255
  • [43] The influence of soy protein and isoflavones on LDL receptor mRNA levels in postmenopausal women
    Teng, HY
    Shay, NF
    Potter, SM
    FASEB JOURNAL, 1996, 10 (03): : 2930 - 2930
  • [44] Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
    Wangen, KE
    Duncan, AM
    Xu, X
    Kurzer, MS
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2001, 73 (02): : 225 - 231
  • [45] Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance
    Llaneza, Placido
    Gonzalez, Celestino
    Fernandez-Inarrea, Jose
    Alonso, Ana
    Diaz-Fernandez, Maria J.
    Arnott, Ignacio
    Ferrer-Barriendos, Javier
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (02): : 372 - 378
  • [46] Potential benefits of soy isoflavones against hypertension and osteoporosis in postmenopausal women.
    Wong, WW
    Jahoor, F
    Smith, EO
    Ellis, KJ
    JOURNAL OF NUTRITION, 2002, 132 (03): : 613S - 613S
  • [47] Various Doses of Soy Isoflavones Do Not Modify Mammographic Density in Postmenopausal Women
    Maskarinec, Gertraud
    Verheus, Martijn
    Steinberg, Francene M.
    Amato, Paula
    Cramer, Margaret K.
    Lewis, Richard D.
    Murray, Michael J.
    Young, Ronald L.
    Wong, William W.
    JOURNAL OF NUTRITION, 2009, 139 (05): : 981 - 986
  • [48] Optimizing soy isoflavones effect in postmenopausal women: the impact of timing on climacteric symptoms
    Cancelo Hidalgo, Maria Jesus
    Castelo Branco, Camil
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (09) : 696 - 700
  • [49] Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women
    Potter, SM
    Baum, JA
    Teng, HY
    Stillman, RJ
    Shay, NF
    Erdman, JW
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06): : 1375S - 1379S
  • [50] HEALTH BENEFITS OF SOY SUPPLEMENTATION IN POSTMENOPAUSAL WOMEN
    Geeta, Kumari
    Mahna, Ranjana
    Khanna, Kumud
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 320 - 320